IMV Technologies
Biotechnology ResearchNormandie, France201-500 Employees
IMV Technologies is a biotechnology research company based in L'aigle, Normandie, France, employing between 201 and 500 people. The company designs, manufactures, and distributes reproductive solutions used by breeders, insemination centers, veterinarians, and academic institutions to support herd improvement. It describes itself as a global, mid-sized organization with opportunities for international collaboration across its global network. Recent corporate activity includes the acquisitions of UD Vet in 2024 and Medivet Scandinavian AB in 2024, and the Belgium-based Veterinarysolutions in 2023. In 2025, Oliver Kohlhaas succeeded Alain de Lambilly as CEO of the IMV Technologies Group. In February 2026, Vitrafy Pty Ltd formed a partnership with IMV Technologies Group.